Infliximab therapy modulates an antigen-specific immune response in chronic beryllium disease
- PMID: 22974830
- PMCID: PMC4347848
- DOI: 10.1016/j.rmed.2012.08.014
Infliximab therapy modulates an antigen-specific immune response in chronic beryllium disease
Conflict of interest statement
Drs. Lisa A. Maier, Lee S. Newman, and Milt Rossman have received research grants from Centocor to support this work. As part of this grant Juliana Barnard and May Gillespie received support to conduct the work for this project. Drs. Lisa Maier and Milton Rossman also direct beryllium testing laboratories and have provided consultation in patient related medicolegal issues.
Similar articles
-
5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.Lung. 2018 Feb;196(1):103-114. doi: 10.1007/s00408-017-0062-x. Epub 2017 Oct 27. Lung. 2018. PMID: 29080069 Clinical Trial.
-
Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis.J Immunol. 2005 Apr 1;174(7):4316-24. doi: 10.4049/jimmunol.174.7.4316. J Immunol. 2005. PMID: 15778396
-
Report of a preliminary discontinued double-blind, randomized, placebo-controlled trial of the anti-TNF-α chimeric monoclonal antibody infliximab in complex regional pain syndrome.Pain Pract. 2013 Nov;13(8):633-40. doi: 10.1111/papr.12078. Epub 2013 May 22. Pain Pract. 2013. PMID: 23692303 Clinical Trial.
-
Chronic beryllium disease: a model interaction between innate and acquired immunity.Int Immunopharmacol. 2002 Feb;2(2-3):249-61. doi: 10.1016/s1567-5769(01)00177-1. Int Immunopharmacol. 2002. PMID: 11811929 Review.
-
[New trends in therapy for arthritis rheumatoid].Nihon Naika Gakkai Zasshi. 2006 Mar 10;95(3):505-9. doi: 10.2169/naika.95.505. Nihon Naika Gakkai Zasshi. 2006. PMID: 16640082 Review. Japanese. No abstract available.
Cited by
-
Pulmonary granulomatosis of genetic origin.Eur Respir Rev. 2021 Apr 29;30(160):200152. doi: 10.1183/16000617.0152-2020. Print 2021 Jun 30. Eur Respir Rev. 2021. PMID: 33927005 Free PMC article. Review.
-
Chronic Beryllium Disease: revealing the role of beryllium ion and small peptides binding to HLA-DP2.PLoS One. 2014 Nov 4;9(11):e111604. doi: 10.1371/journal.pone.0111604. eCollection 2014. PLoS One. 2014. PMID: 25369028 Free PMC article.
-
Innate and Adaptive Immunity in Noninfectious Granulomatous Lung Disease.J Immunol. 2022 Apr 15;208(8):1835-1843. doi: 10.4049/jimmunol.2101159. J Immunol. 2022. PMID: 35418504 Free PMC article. Review.
-
Effect of inhaled corticosteroids on lung function in chronic beryllium disease.Respir Med. 2018 May;138S:S14-S19. doi: 10.1016/j.rmed.2018.01.009. Epub 2018 Feb 5. Respir Med. 2018. PMID: 29453139 Free PMC article.
-
5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.Lung. 2018 Feb;196(1):103-114. doi: 10.1007/s00408-017-0062-x. Epub 2017 Oct 27. Lung. 2018. PMID: 29080069 Clinical Trial.
References
-
- Henneberger PKG, Sandra K, Miller William E, Doney Brent, Groce Dennis W. Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed. J Occup Environ Hyg. 2004;1:648–59. - PubMed
-
- Samuel GM, Lisa A. Immunology of chronic beryllium disease. Curr Opin Allergy Clin Immunol. 2008;8:126–34. - PubMed
-
- Schuler CRK, Michael S, Deubner David C, Berakis Michael T, McCawley Michael, Henneberger Paul K, Rossman Milton D, Kreiss Kathleen. Process-related risk of beryllium sensitization and disease in a copper–beryllium alloy facility. Am J Ind Med. 2005;47:195–205. - PubMed
-
- Henneberger PKC Debra, Deubner David D, Kent Michael S, McCawley Michael, Kreiss Kathleen. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Int Arch Occup Environ Health. 2001;74:167–76. - PubMed
-
- Daniloff EMB, Bucher Becki, Newell John D, Jr, Bernstein Steven M, Newman Lee S. Observer variation and relationship of computed tomography to severity of beryllium disease. Am J Respir Crit Care Med. 1997;155:2047–56. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical